Author

Alexander Kinna

Observed name: Alex Kinna

Institution: Autolus (United Kingdom)

Observed institutions: Autolus (United Kingdom), University College London

ORCID: 0000-0003-4854-5221

Observed ORCID: 0000-0003-4854-5221

OpenAlex ID: A5044689250

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants

2021 · Mathieu Ferrari, Leila Mekkaoui, et al. · Journal of Virology · 38

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

2024 · Mathieu Ferrari, Matteo Righi, et al. · Nature Communications · 26

Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments

2020 · Francesco Nannini, Lenart Senicar, et al. · mAbs · 24

IMAC capture of recombinant protein from unclarified mammalian cell feed streams

2015 · Alexander Kinna, Berend Tolner, et al. · Biotechnology and Bioengineering · 20

Structure Guided Engineering of Highly Specific Chimeric Antigen Receptors for the Treatment of T Cell Lymphomas

2018 · Shimobi Onuoha, Mathieu Ferrari, et al. · Blood · 10

Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction

2024 · Ram Jha, Alexander Kinna, et al. · ACS Chemical Biology · 8

Antibody format matters: A comparative analysis of VHH and scFv domains reveals superior in vivo CAR T cell function with VHH domains

2026 · Alexander Kinna, Preeta Datta, et al. · Molecular Therapy · 1

Works count: 7

Citation count: 127

H-index: 6

I10-index: 5